Approval for Aservo EquiHaler equine asthma therapy

Boehringer Ingelheim receives approval for Aservo ® EquiHaler®, industry first therapy for severe equine asthmaAservo ®EquiHaler® (ciclesonide inhalation solution) is a result of synergies between human pharma and animal health businessesThe inhaler addresses an unmet need in the equine segmentThe company continues to set new standards of care to strengthen its commitment to animal welfare
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news